Title
PHASE II STUDY OF IBERDOMIDE (CC220) MAINTENANCE AFTER AUTOLOGOUS STEM CELL TRANSPLANTION IN NEWLY DIAGNOSED MULTIPLE MYELOMAStudy map
Overview / Summary
The study is conducted in co-sponsorship with EMN Trial Office s.r.l. i.s.
Study details
The study focuses on maintenance during first line of therapy and 120 patients have been enrolled.
Patient eligibility criteria
Newly diagnosed multiple myeloma (NDMM) patients in at least partial response (PR) after induction with proteasome inhibitors (PIs) plus IMIDs and single or double ASCT
